| payload |
{"created_at":"2026-04-16T21:26:03.714 {"created_at":"2026-04-16T21:26:03.714399+00:00","signal_type":"news_headline_delta","source":"news_rss","url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9nRDF3Mm9YUGd6Rkg4UXAyR1NSdkhKM1BkOXdhSnhXeGpULXZObVpFNDMweDhNWklrM29GZnNLQVJRV1lyUjFaa0hmRjFLbm1pcDd5MWJRX1NqdW1ONUZORE9hakM3amxrNWZGZEJVNDVLNVJUeC1n0gF8QVVfeXFMTUlqNEE5WVdrMFdia1RKUG5JYk0wZ3N0bXlUSGx0R19LWmxnTV9rV2RyTHlUelN4aWZpUHFrcHdfOWw3eWZFbi1XOU45YzMyUEgtV3hvdXQyU3FlYlBFT3Z0U2xNNTROaFlFN3Rhd0pUTmkta1lXcTYxWDA2Sw?oc=5","value":{"fp":"f8887882ff59bb4a","published_at":"2026-04-16T17:44:50+00:00","source":"CNBC","source_domain":"cnbc.com","source_url":"https://www.cnbc.com","summary":"RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves CNBC Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides MarketWatch The Trump administration is looking to experts to weigh in on peptides Scientific American FDA advisory committee set to weigh taking action on certain unapproved peptides Fierce Pharma FDA moves toward easing restrictions on certain peptides BioPharma Dive","title":"RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves - CNBC","url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9nRDF3Mm9YUGd6Rkg4UXAyR1NSdkhKM1BkOXdhSnhXeGpULXZObVpFNDMweDhNWklrM29GZnNLQVJRV1lyUjFaa0hmRjFLbm1pcDd5MWJRX1NqdW1ONUZORE9hakM3amxrNWZGZEJVNDVLNVJUeC1n0gF8QVVfeXFMTUlqNEE5WVdrMFdia1RKUG5JYk0wZ3N0bXlUSGx0R19LWmxnTV9rV2RyTHlUelN4aWZpUHFrcHdfOWw3eWZFbi1XOU45YzMyUEgtV3hvdXQyU3FlYlBFT3Z0U2xNNTROaFlFN3Rhd0pUTmkta1lXcTYxWDA2Sw?oc=5"}}... |